Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) is routinely used for advanced or metastasized neuroendocrine tumours (NET). To prevent nephrotoxicity, positively charged amino acids (AA) are co-infused. The aim of this study was to correlate the risk for therapy-related hyperkalaemia with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EJNMMI Res
Egile Nagusiak: Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lückerath, Katharina, Schirbel, Andreas, Strate, Alexander, Buck, Andreas K, Herrmann, Ken
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4412194/
https://ncbi.nlm.nih.gov/pubmed/25977877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0046-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak